COMP <GO>
VTRS vs MRK // NET PROFIT MARGIN
Viatris Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: VTRS 3
— MRK 11
▲ NET PROFIT MARGIN LEADER: MRK
LAST: $19.04 (-0.83%) • MKT CAP: $22.05B
net-margins
-14.60%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VTRS VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VTRS | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.20% | 74.80% | -39.60 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -8.10% | 20.70% | -28.80 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.78% | 3.42% | +5.36 | VTRS | /fcf-yield <GO> |
| Operating Margin | -18.70% | 34.30% | -53.00 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -14.60% | 28.10% | -42.70 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -3.00% | 1.30% | -4.30 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.81 | 5.19 | -4.38 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.60% | +0.80 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.1 | 56.9 | +7.28 | VTRS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 0.92 | +0.23 | VTRS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.0x | 18.4x | +14.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.05B | $361.02B | -$338.97B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VTRS REV | MRK REV | VTRS GROSS % | MRK GROSS % | VTRS FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $14.25B | $65.01B | 35.2% | 74.8% | $1.94B | $12.36B |
| FY 2024 | $14.69B | $64.17B | 38.3% | 76.3% | $1.98B | $18.10B |
| FY 2023 | $15.39B | $60.12B | 44.0% | 44.0% | $2.21B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VTRS // BETA 1.15
MRK // BETA 0.92